90 related articles for article (PubMed ID: 8755216)
1. [The whole dose at once?].
Rodríguez García J; Ramos Ortega FJ; Sandoval Guerra V; García Sanz R
Sangre (Barc); 1996 Jun; 41(3):259. PubMed ID: 8755216
[No Abstract] [Full Text] [Related]
2. Safety and efficacy of once-per-cycle pegfilgrastim in support of ABVD chemotherapy in patients with Hodgkin lymphoma.
Younes A; Fayad L; Romaguera J; Pro B; Goy A; Wang M
Eur J Cancer; 2006 Nov; 42(17):2976-81. PubMed ID: 17008093
[TBL] [Abstract][Full Text] [Related]
3. [Hodgkin lymphoma--ABVD regimen].
Nagai H
Nihon Rinsho; 2015 Feb; 73 Suppl 2():642-5. PubMed ID: 25831839
[No Abstract] [Full Text] [Related]
4. [Cardiogenic shock during polychemotherapy in a patient with Hodgkin's disease].
Drzewoski J; Chojnowski K; Olszańska-Skorek T; Krykowski E
Kardiol Pol; 1986; 29(8):555-9. PubMed ID: 2435945
[No Abstract] [Full Text] [Related]
5. A case with Hodgkin lymphoma and fronto-temporal lobular degeneration (FTLD)-like dementia facilitated by chemotherapy.
Katsumata R; Sagawa R; Akechi T; Shinagawa Y; Nakaaki S; Inagaki A; Okuyama T; Akazawa T; Furukawa TA
Jpn J Clin Oncol; 2010 Apr; 40(4):365-8. PubMed ID: 20026458
[TBL] [Abstract][Full Text] [Related]
6. Intermittent G-CSF to maintain dose intensity of chemotherapy for Hodgkin's disease.
Clarke K; Grigg A
Leuk Lymphoma; 1995 Nov; 19(5-6):521-2. PubMed ID: 8590858
[No Abstract] [Full Text] [Related]
7. [Hodgkin's disease in pregnancy--case report and literature review].
Schäffer M; Hegenbart U; Klostermann K; Stepan H
Z Geburtshilfe Neonatol; 2003; 207(2):71-3. PubMed ID: 12740750
[TBL] [Abstract][Full Text] [Related]
8. Cutaneous flagellate pigmentation by bleomycin.
Spedini P; Bergonzi C; Morandi S
Haematologica; 2000 Aug; 85(8):870. PubMed ID: 10942936
[No Abstract] [Full Text] [Related]
9. Pohl-Pinkus constrictions of hair following chemotherapy for Hodgkin's disease.
Williamson PJ; de Berker D
Br J Haematol; 2005 Mar; 128(5):582. PubMed ID: 15725077
[No Abstract] [Full Text] [Related]
10. A dose-seeking trial of edatrexate in combination with vinblastine, adriamycin, cisplatin, and filgrastim (EVAC/G-CSF) in patients with advanced malignancies: promising antineoplastic activity against non-small cell lung carcinomas.
Colón-Otero G; Marschke R; Camoriano JK; Sorensen JM; Sloan JA; Richardson RL
Cancer J Sci Am; 1997; 3(5):297-302. PubMed ID: 9327154
[TBL] [Abstract][Full Text] [Related]
11. Myeloid toxicity in breast cancer patients receiving adjuvant chemotherapy: what is the appropriate use of filgrastim?
Ferretti G; Lopez M; Terzoli E; Cortesi E; Antimi M; Marolla P; Giannarelli D; Cognetti F; Papaldo P
J Clin Oncol; 2006 Dec; 24(35):5618-9. PubMed ID: 17158554
[No Abstract] [Full Text] [Related]
12. [Dicarbamin--an effective protector of myelodepression in combined treatment for Hodgkin's disease].
Gershanovich ML; Filatova LV
Vopr Onkol; 2007; 53(5):589-95. PubMed ID: 18154127
[TBL] [Abstract][Full Text] [Related]
13. Treatment of Hodgkin lymphoma with adriamycin, bleomycin, vinblastine and dacarbazine without routine granulocyte-colony stimulating factor support does not increase the risk of febrile neutropenia: a prospective cohort study.
Minuk LA; Monkman K; Chin-Yee IH; Lazo-Langner A; Bhagirath V; Chin-Yee BH; Mangel JE
Leuk Lymphoma; 2012 Jan; 53(1):57-63. PubMed ID: 21740297
[TBL] [Abstract][Full Text] [Related]
14. Hodgkin's disease and the risk of acute leukemia in successfully treated patients.
Valagussa P; Bonadonna G
Haematologica; 1998 Sep; 83(9):769-70. PubMed ID: 9825571
[No Abstract] [Full Text] [Related]
15. [Sarcoidosis-like reaction after treatment with doxorubicin, bleomycin, vinblastine and dacarbazine in a patient with Hodgkin's lymphoma].
Torrent A; Navarro JT; Andreo FC; Ribera JM
Med Clin (Barc); 2013 Aug; 141(3):134-5. PubMed ID: 23332624
[No Abstract] [Full Text] [Related]
16. [Effect of high-dose chemotherapy with subsequent transplantation of blood-forming cells on left ventricle function in patients with malignant lymphomas treated with doxorubicin in primary chemotherapy].
Elbl L; Vásová I; Krejcí M; Navrátil M; Tomásková I; Jedlicka F; Chaloupka V; Mayer J; Vorlícek J
Vnitr Lek; 2006 Mar; 52(3):221-31. PubMed ID: 16722153
[TBL] [Abstract][Full Text] [Related]
17. Cardiopulmonary response to exercise in patients with different degrees of lung toxicity after radio-chemotherapy for Hodgkin's disease.
Villani F; Busia A; Villani M; Laffranchi A; Viviani S; Bonfante V
Anticancer Res; 2009 Feb; 29(2):777-83. PubMed ID: 19331235
[TBL] [Abstract][Full Text] [Related]
18. Mees' lines because of chemotherapy for Hodgkin's lymphoma.
Piccolo V; Corneli P; Zalaudek I; Argenziano G; Conforti C; Alfano R; Russo T
Int J Dermatol; 2020 Feb; 59(2):e38. PubMed ID: 31566709
[No Abstract] [Full Text] [Related]
19. [Is the ABVD an optimal regimen for Hodgkins disease?].
Nakamura S
Rinsho Ketsueki; 1998 Feb; 39(2):109-10. PubMed ID: 9545813
[No Abstract] [Full Text] [Related]
20. [Risk factors for hematologic toxicity and multifaceted analysis of blood in Hodgkin's disease: a model for hematologic toxicity].
Datsenko PV; Podol'skiĭ PN; Pan'shin GA; Sotnikov VM; Bozhenko VK
Vopr Onkol; 2010; 56(5):571-5. PubMed ID: 21137237
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
